SPERATUM.COM

headerweb-01.png

About

 
 

 

 

Speratum is a biotechnology company developing innovative, targeted molecular therapies or the treatment of cancer. We combine the latest advances in synthetic biology with a revolutionary drug delivery system, originally developed at Baylor College of Medicine and licensed exclusively to Speratum.

The company was founded in 2014 by the co-inventor of its core technologies, Dr. Christian Marín-Müller through a partnership with Carao Ventures, the leading technology investment firm and start up accelerator in the region. Since then, the company has expanded its patent portafolio to transform the technology from a single focus therapeutic to a flexible, reprogrammable molecular scaffold, fully adaptable to a variety oligonucleotide-based therapeutics.

We are currently completing a pre-clinical development of our novel therapeutic platform, testing efficacy and safety in animal models, and plan to take our first product to the clinic within the next 12-18 months.

If you would like to have more information about our technology, please contact us with our Contact Us form.

 

IMG_5731.jpg
 

Contact Us

For career opportunities and general inquiries, please contact us with the following form:

 

Please complete the form below

Name *
Name